Van, H., E. Jonaitis, T. Betthauser, R. Batrla, N. Wild, G. Kollmorgen, U. Andreasson, O. Okonkwo, B. Bendlin, S. Asthana, C. Carlsson, S. Johnson, H. Zetterberg, and K. Blennow. “An Examination of a Novel Multipanel of CSF Biomarkers in the Alzheimer’s Disease Clinical and Pathological Continuum.”. Alzheimer’s & Dementia : The Journal of the Alzheimer’s Association, 2020.
This study examines the utility of a multipanel of cerebrospinal fluid (CSF) biomarkers complementing Alzheimer’s disease (AD) biomarkers in a clinical research sample. We compared biomarkers across groups defined by clinical diagnosis and pTau181 /Aβ42 status (+/-) and explored their value in predicting cognition.
DOI: 10.1002/alz.12204
PubMed: 33336877